Prolor Closes at Highest Since December on Clotting Factor

Feb. 14 (Bloomberg) -- Prolor Biotech Inc. closed at its highest since December after saying its long-acting clotting factor may provide hemophilia patients with prolonged protection from bleeding episodes.

Shares climbed 3 percent to 24.41 shekels at the 4:30 p.m. close in Tel Aviv, the highest level since Dec. 27.

Link to Company News: {PBTH US <Equity> CN <GO>}

To contact the reporter on this story: Gwen Ackerman in Jerusalem at gackerman@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net